Joint Operations’ non-surgical product line now boasts the revolutionary imaging solution by Trice Medical that allows surgeons to perform a full diagnostic arthroscopy in an outpatient clinic setting.
The mi-eye 2 is a handheld arthroscope consisting of a 19-gauge cannula and needle with an integrated camera and light source, which provides illumination and visualisation of an interior cavity of the body through either a natural or surgical opening.
It provides a 120° field of view and a 5mm-35mm depth of field, offering an expanded perspective of the joint and giving surgeons a real-time analysis. Users are also offered options to view, save and share images and videos via the ‘Trice Tablet’, a dedicated HD tablet, supplied with the scope.
Aside from offering speed of diagnosis, the mi-eye 2 is an ideal alternative or adjunct to a traditional MRI. It is especially well suited for patients with inconclusive scans, or those with pacemakers, metal implants, obesity and claustrophobia or anxiety.
A survey of 300 patients, commissioned by Trice Medical showed that:
- 86 per cent of patients value a diagnosis within their first clinic visit.
- 89 per cent of patients prefer the option of mi-eye over MRI, given the benefits of both.
- 95 per cent of patients value real time diagnosis over cost.
mi-eye 2 also perfectly aligns with Joint Operations’ #savethejoint ethos, offering that early look and clear picture on what treatment options could be necessary. Joint Operations can then support a cartilage, meniscal, ligament and alignment treatment pathway, or indeed further non- surgical (celluar and non-celluar injections) options.